Jnana
A clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet need. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD584—875m (Dealroom.co estimates Nov 2022.)
Boston Massachusetts (HQ)
Authorizing premium user...